Abbott’s $5B acquisition of Alere set to close tomorrow

This article was originally published here

Abbott to acquire Alere

Abbott (NYSE:ABT) said today it is looking to close its $5 billion acquisition of Alere (NYSE:ALR) tomorrow, saying it has received all regulatory clearances necessary.

The Abbott Park, Ill.-based company said the acquisition will establish it as a “global leader in point of care testing,” which it sees as the fastest growing segment of the $50 billion in vitro diagnostics market.

Read the whole story at our sister site, Drug Delivery Business

The post Abbott’s $5B acquisition of Alere set to close tomorrow appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply